HTA Alerts

Health technology assessment (HTA) is a multidisciplinary process that summarizes information about the medical, social, economic, and ethical issues related to the use of medical technologies in a systematic, transparent, unbiased, and robust manner.

The key objective of HTA is to advise policymakers and providers about the necessity of adopting and appropriateness of reimbursing procedures, devices, and In-Vitro Diagnostics (IVD) tests.

Most developed countries have functioning HTA frameworks on different levels (national, regional, and hospital-based). In Europe alone, three hundred and thirty-seven med tech HTA reports were released in 2018, with two hundred and fifty-six reports in 2019.

HTA plays an important role in the market access landscape for medical technologies. Very often, HTA is a formal part of the reimbursement or funding processes (e.g., in France or Norway). Even if not formally connected to the reimbursement process, HTA still significantly impacts the adoption of technologies (e.g., in England).

Market access professionals closely monitor initiated and published HTAs for the products under their supervision. The key challenges for effective monitoring are the large number of HTA organizations, language barriers, and lack of time to properly perform the necessary monitoring.

MTRC offers a unique service of monitoring developments with initiated or published HTA reports for medical technologies globally, so that our clients do not miss a single HTA for their technology.

Key features of the HTA Alerts service

More than 500 HTA reports (published, initiated, ongoing) globally are detected every two weeks (about 300 hundred reports in Europe alone).

Global coverage

The service includes key HTA organisations in Europe as well as globally (Argentina, Australia, Brazil, Canada, Chile, Colombia, Japan, Malaysia, Mexico, Peru, Singapore, South Africa, South Korea, Taiwan, Thailand, UAE and the United States of America). In total, 68 active HTA organizations from 36 countries producing Med Tech-related HTA reports, are included

All types of HTA organizations are included

The service includes international (e.g., EUnetHTA), national and regional HTAs, with a total of 68 organizations. These organizations were selected based on an audit of their activity

Timely alerts with essential information presented in English

Alerts about initiated or published HTAs are emailed every two weeks. Each report is made up of a title, a brief summary in English and the link which can be followed to further investigate each report. Each newsletter covers the HTAs that were initiated/published during the last two weeks

Both general and technology-specific news are included

The service captures both general (e.g., a new program at NICE, or termination of work of Swiss Medical Board) and technology-specific (e.g., new HTA for transcatheter aortic valve implantation) news

All reports are classified according to 31 technology groups

The service helps to focus only on technologies of interest (e.g., cardiovascular or neuromodulating devices) and avoids wasting time on irrelevant reports

Personalized alerts and an unlimited number of subscribers

All reports are customized based on the client's preferences about geographical and technological coverage, where the client can select the countries and technologies for monitoring. The number of enrolled subscribers from one company is unlimited

Reports are developed using a manual search

The search and categorization of identified reports are performed manually by MTRC analysts – no search robots are utilized for identification and clarification of relevant information

Three-month free, no-obligation trial

Evaluate our service in real-time before subscribing

Trusted by 40% of the top 30 global med tech companies

Why use "HTA Alerts"?

Timely access to essential information

Be the first to know about important technology developments within the company and across your competitors. New HTA reports reveal new opportunities for your company's business

Ability to engage with HTA stakeholders

Being informed about initiated assessment means that our clients can engage with HTA bodies in a timely manner to provide the relevant information about their technology, thereby increasing the chances of more unbiased assessment and a positive HTA result

Cost-effective approach

An external HTA monitoring service saves our clients both time and money, since no single med tech company can afford such large-scale screening and monitoring activities. By outsourcing this essential function, our clients keep their companies up to date at a modest expense. MTRC offers both quarterly and annual payment options

Suitable for both middle-size companies and large corporations

Our HTA alert service is suitable for both middle-sized companies (with one to two people in the market access function) and large corporations. For small companies, this service is the only opportunity to keep track of significant developments, and for large corporations, it complements the internal effort

Customized information in a user-friendly format

Clients obtain access to HTA information only for countries and technologies of relevance to their position, for example EMEA region only or peripheral vascular technologies only. Newsletters are easy to navigate and easy to distribute internally

More professional fulfillment of the market access role

Market access professionals use all modern tools at their disposal to execute their function professionally. "HTA Alerts" has become a new industry standard and an essential tool in the portfolio of market access specialists

Ready for a three-month free, no-obligation trial?

Contact us Contact us Contact us Contact us to discuss your needs Contact us to discuss your needs Contact us to discuss your needs

Key features of the HTA Alerts service

Trusted by 40% of the top 30 global med tech companies

Why use "HTA Alerts"?

Get in touch